There is an urgent need for an updated population study designed to assess the current rate of this fungal infection in users of TNF-α inhibitors, as well as to understand possible factors contributing to this increased incidence, such as associated immunosuppressive medications or a broader use in people more vulnerable in endemic areas. The gene discussed is TNF; the disease is fungal infectious disease.